-
Alembic Pharma Gets USFDA Final Approval for Parkinson's Drug Stalevo Generic
07 Feb 2026 20:47 GMT
… its Abbreviated New Drug Application (ANDA) for Carbidopa, Levodopa and Entacapone Tablets … product is indicated for the treatment of Parkinson’s disease, with … manufacturing, and regulatory compliance.
Alembic Pharmaceuticals Limited, founded in 1907, is …
-
Alembic Pharma gets U.S. FDA nod for generic Parkinson’s drug
06 Feb 2026 19:33 GMT
Alembic Pharmaceuticals has received U.S. Food and Drug Administration … abbreviated new drug application for Carbidopa, Levodopa and Entacapone … The combination drug is indicated for the treatment of Parkinson’ … announcing the U.S. FDA approval.
The company’s …
-
Aucta Pharmaceuticals, Inc. (“Aucta Pharmaceuticals”) prepares for the launch of PYQUVI™ (deflazacort) oral suspension, the first of a new branded-generic rare disease product line
06 Feb 2026 13:22 GMT
… Pharmaceuticals’ branded generic portfolio. It also underscores our commitment to providing treatment … times of medical stress.
… clearly not drug related.
… trial; response cannot be pre-determined by laboratory testing.
Interactions with Levodopa …
-
Alembic Pharmaceuticals gets USFDA nod for generic Parkinson's disease treatment tablets
06 Feb 2026 09:19 GMT
Synopsis
Alembic Pharmaceuticals has secured a significant approval … ;s generic version of Carbidopa, Levodopa, and Entacapone tablets, used for …
-
Alembic Pharmaceuticals gets USFDA final approval for Carbidopa, Levodopa and Entacapone tablets
06 Feb 2026 08:57 GMT
Alembic Pharmaceuticals Limited has announced … Abbreviated New Drug Application (ANDA) for Carbidopa, Levodopa and Entacapone … to the reference listed drug Stalevo Tablets, originally developed … are widely prescribed for the treatment of Parkinson’s disease, …
-
Discovery of brain network that links body and mind could open the door to better Parkinson’s treatments
04 Feb 2026 17:35 GMT
… of the main treatments available, primarily the drug levodopa, as well … results show that effective treatments reduce the hyperconnectivity of … Ferro. Before that, clinical trials will have to be … accuracy of certain non-invasive treatments. The study, the …
-
Phase 2 Trial Assesses c-Abl Inhibitor for Early Parkinson’s
03 Feb 2026 22:51 GMT
… advances in symptomatic treatments, notably levodopa and dopamine agonists … therapeutic intervention.
This trial’s multidimensional evaluation … . The convergence of medicinal chemistry, biomarker science, … optimism for subsequent trials and eventual clinical …
-
Silver Economy Boom: Investing in Healthcare's Aging Tailwinds
03 Feb 2026 22:03 GMT
… investment opportunities across pharmaceuticals, medical devices, home care … demand for critical treatments, pharmaceuticals and procedures stays … innovation, securing FDA clearance in December … hour continuous subcutaneous levodopa infusion, designed to …
-
Merz steps into the ring with Muhammad Ali-inspired Inbrija campaign
06 Feb 2026 02:08 GMT
… campaign for Parkinson’s disease drug Inbrija, working Muhammad Ali … address OFF episodes with INBRIJA (levodopa inhalation powder), the only inhaled … levodopa that helps them fight back … symptoms return despite regular medication.
-
‘Extraordinary’ brain network discovery changes our understanding of Parkinson’s disease
05 Feb 2026 02:27 GMT
… in Nature. The results change doctors’ understanding of what causes Parkinson … found that existing treatments for Parkinson’s, including the medication levodopa (also known …